Covered recipient · General Payments record
JEFFREY M BURNS
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$90,619.88
- Reported across 82 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $37,713.75 | 9 |
| Travel and Lodging | $4,806.92 | 17 |
| Food and Beverage | $889.37 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $12,644.78 | 13 |
| EISAI INC. | $11,407.50 | 4 |
| Novo Nordisk AS | $10,373.26 | 8 |
| ABBVIE INC. | $8,984.50 | 10 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $125.00 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103394559 | CMS |
| ABBVIE INC. | $198.00 | 10/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104179328 | CMS |
| ABBVIE INC. | $25.00 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103394561 | CMS |
| ABBVIE INC. | $50.00 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103394563 | CMS |
| ABBVIE INC. | $25.00 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103394565 | CMS |
| ABBVIE INC. | $50.00 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103394567 | CMS |
| ABBVIE INC. | $99.00 | 10/11/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104179330 | CMS |
| ABBVIE INC. | $1,186.46 | 10/11/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104179332 | CMS |
| ABBVIE INC. | $7,200.00 | 11/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103132515 | CMS |
| ABBVIE INC. | $26.04 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103394569 | CMS |
| Eisai Inc. | $4,095.00 | 03/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110751682 | CMS |
| Eisai Inc. | $1,755.00 | 04/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110751686 | CMS |
| Eisai Inc. | $2,632.50 | 09/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110751684 | CMS |
| Eisai Inc. | $2,925.00 | 09/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110751688 | CMS |
| Lilly USA, LLC | $42.33 | 05/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135010501 | CMS |
| Lilly USA, LLC | $42.33 | 05/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135037341 | CMS |
| Lilly USA, LLC | $249.00 | 05/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135039385 | CMS |
| Lilly USA, LLC | $42.33 | 05/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135039387 | CMS |
| Lilly USA, LLC | $42.33 | 05/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135054290 | CMS |
| Lilly USA, LLC | $249.00 | 05/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135054292 | CMS |
| Lilly USA, LLC | $249.00 | 05/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135058894 | CMS |
| Lilly USA, LLC | $435.34 | 05/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135058990 | CMS |
| Lilly USA, LLC | $249.00 | 05/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135058992 | CMS |
| Lilly USA, LLC | $8,750.00 | 05/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1135037339 | CMS |
| Lilly USA, LLC | $2,200.00 | 05/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1135038727 | CMS |
| Lilly USA, LLC | $44.12 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135039383 | CMS |
| Lilly USA, LLC | $50.00 | 05/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135054288 | CMS |
| Novo Nordisk Inc | $19.27 | 07/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096890596 | CMS |
| Novo Nordisk Inc | $1,312.50 | 11/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1097258252 | CMS |
| Novo Nordisk Inc | $6,843.75 | 11/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1096589546 | CMS |
| Novo Nordisk Inc | $379.14 | 11/06/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1096754696 | CMS |
| Novo Nordisk Inc | $614.00 | 11/06/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1096820769 | CMS |
| Novo Nordisk Inc | $524.94 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097056621 | CMS |
| Novo Nordisk Inc | $46.90 | 11/06/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1097107574 | CMS |
| Novo Nordisk Inc | $632.76 | 11/06/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1097576669 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.